Kaitlyn Bader, Associate Editor

Tazarotene lotion uses polymeric emulsion technology to improve skin barrier function, according to a poster presentation at the 2022 SDPA Conference.

Andrew Alexis, MD, shares his best tips for appropriate laser use in skin of color patients at the 2022 SDPA Conference.

A poster presentation from the 2022 SDPA Conference reviewed an elastic-scattering spectroscopy device for melanoma detection.

Shanna Miranti, MPAS, PA-C, shares highlights from her shared session at the 2022 SDPA Conference.

At the 2022 SDPA Conference, Lucia Diaz, MD, reviews literature updates to help physicians better care for pediatric patients.

Zeena Nawas, MD, discussed the clinical presentations, evaluation, and management of high-risk cutaneous tumors at the 2022 SDPA Conference.

Shanna Miranti, MPAS, PA-C, shares highlights from her first session at the 2022 SDPA Conference in Miami, Florida.

At the 2022 SDPA Conference, Ted Rosen, MD, discusses how to use off-label therapeutics for adult dermatologic conditions to optimize treatments.

At a poster presentation at the 2022 SDPA Conference, patients with psoriasis reported symptoms in intertriginous areas at some point during the duration of their psoriasis.

At the 2022 SDPA Conference, Orit Markowitz, MD, reviews dermoscopy and other imaging modalities that allow for more practical ways to treat patients' lesions.

As the Society of Dermatology Physician Assistants Conference begins this week, speakers share what they’re excited about.

This week's edition of the Mainstream Patient features stories about "botox in a bottle" products, how to treat cystic acne, face positivity, and more.

Click here to see a preview of what to expect this week.

ICYMI, this week we had stories about IL-17 inhibitor durability in plaque psoriasis, benzene contamination in dry shampoo products, an interview with Muneeb Shah, DO, and more.

Dermavant announced positive results from its pediatric maximal usage study.

BLA submission is based on phase 3 trial results evaluating the safety and efficacy of lebrikizumab.

November kicks off National Healthy Skin Month, presenting an opportunity to learn new habits for healthier skin.

Valisure, an independent laboratory, recently sent a Citizen's Petition to the FDA regarding high levels of benzene found in dry shampoo products.

Brexogen Inc.’s exosome therapy is the first entry of a clinical trial of exosome treatment for atopic dermatitis.

This week's edition of the Mainstream Patient features stories about how to take care of the skin's microbiome, Clinique's commitment to the Latinx community, laser treatment results for rosacea, and more.

ICYMI, this week we had stories about blastic plasmacytoid dendritic cell neoplasm, epidermolysis bullosa, an interview with Seth Matarasso, MD, and more.

Christopher Bunick, MD, PhD, shares his thoughts on the latest report of concerning levels of benzene, a human carcinogen, found in dry shampoos recalled last month.

Seth Matarasso, MD, discusses upcoming innovations in neuromodulators and additional highlights from his presentation at ASDS in Denver, Colorado.

Numerous adverse effects are associated with standard-dose isotretinoin.

Patient-reported outcome measures ensure patients' experiences are documented during new treatments.

Each month, Dermatology Times® features a roundup of products trending in skin care. Find out what products are trending for the month of October.

ICYMI, this week we had stories about product recalls due to benzene, advanced wound care in the US, a Fall Clinical recap, and more.

Catch up on coverage from the 2022 Fall Clinical Dermatology Conference.

State of Skin Sensitivity Report raises awareness of the causes of skin sensitivity and its effect on the mind.

Amryt Pharma’s phase 3 trial, EASE, is the largest phase 3 trial in epidermolysis bullosa.